NORGES BANK - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 156 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NORGES BANK ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q2 2022$31,287,144
+216.0%
415,776
+12.7%
0.01%
+300.0%
Q1 2022$9,901,824
-38.0%
368,783
+10.2%
0.00%
-33.3%
Q4 2021$15,969,000
-28.2%
334,7830.0%0.00%
-40.0%
Q3 2021$22,240,000
-16.4%
334,783
-1.8%
0.01%
-16.7%
Q2 2021$26,601,000
-15.4%
340,954
+2.6%
0.01%
-14.3%
Q1 2021$31,435,000
-35.1%
332,330
-16.4%
0.01%
-36.4%
Q4 2020$48,462,000
+66.2%
397,718
+19.2%
0.01%
+37.5%
Q3 2020$29,155,000
+60.6%
333,736
+18.7%
0.01%
+60.0%
Q2 2020$18,159,000
+57.0%
281,141
+8.6%
0.01%
+25.0%
Q1 2020$11,564,000258,9400.00%
Other shareholders

There were no reported owners of TURNING POINT THERAPEUTICS I in Q1 2022.

NameSharesValueWeighting ↓
View complete list of TURNING POINT THERAPEUTICS I shareholders